CLCA2


Summary: This gene encodes a member of the calcium-activated chloride channel regulator (CLCR) family of proteins. Members of this family regulate the transport of chloride across the plasma membrane. The encoded protein is autoproteolytically processed to generate N- and C- terminal fragments. Expression of this gene is upregulated by the tumor suppressor protein p53 in response to DNA damage. In breast cancer, expression of this gene is downregulated and the encoded protein may inhibit migration and invasion while promoting mesenchymal-to-epithelial transition in cancer cell lines. [provided by RefSeq, Sep 2016].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in CLCA2


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF TAS GO:0004222 metalloendopeptidase activity
MF IBA GO:0005229 intracellular calcium activated chloride channel activity
MF TAS GO:0005254 chloride channel activity
MF IEA GO:0015276 ligand-gated ion channel activity
MF IEA GO:0046872 metal ion binding
CC IEA GO:0005576 extracellular region
Showing 1 to 6 of 19 rows rows per page

Gene expression in normal tissue: CLCA2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in CLCA2


Loading, please wait...
Database
Pathway ID
Pathway Des.
pid p73pathway p73 transcription factor network
pid tap63pathway Validated transcriptional targets of TAp63 isoforms
kegg hsa04924 Renin secretion - Homo sapiens (human)
kegg hsa04972 Pancreatic secretion - Homo sapiens (human)
reactome R-HSA-2672351 Stimuli-sensing channels
reactome R-HSA-382551 Transport of small molecules
Showing 1 to 6 of 7 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD133 Lapatinib 2
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in CLCA2

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​